Table: begin end state 1 16 non-cytoplasmic 17 38 transmembrane 39 61 cytoplasmic 62 88 transmembrane 89 92 non-cytoplasmic 93 116 transmembrane 117 141 cytoplasmic 142 162 transmembrane 163 175 non-cytoplasmic 176 198 transmembrane 199 206 cytoplasmic 207 228 transmembrane 229 247 non-cytoplasmic 248 257 transmembrane 258 300 cytoplasmic 301 323 transmembrane 324 345 non-cytoplasmic 346 367 transmembrane 368 386 cytoplasmic 387 410 transmembrane 411 415 non-cytoplasmic 416 437 transmembrane 438 488 cytoplasmic
Input: >7025996 FitnessBrowser__ANA3:7025996 MLETIVNFLNALLWGKLLVYGLVGAGLYFTLRLVFIQLTHFKHSLKVMTMSRQGCESGLS SFQVFCTSMAARVGAGNMAGVAVAIGAAGPGAVFWMWLIAMLGMATAMVESTLAQVYKVR DTNGQFRGGPSYYMEKGLGQRWMGVLFAFFLIIAFGLVFNAVQANTITGAMERVFGFNPT YVGIGLVLASGFVIVGGLRKVARVSEFIVPIMALAYILIAFIIVLFNLDQLPAIISLIVK SAFGWQEAAAGGVAYTVAQAMQAGIARGLFSNEAGMGSAANVAASASPNPNHPASQGFVQ MMGVFVDTIVICTATAAIILLSGDIGSSEDGIRLTINAMSNHVGDWGGAFIAIAIFLFCF TSIIANYSYAETNVMFLTGNSTKALPLFRLCVLGMVMFGAVAKISLVWNLADVSMGLMAT VNIIALLLLSGLAIRVINDYCEQLKSGKMPEFDRSKFPELMEQLDDGIWQDNSANEQAKA RTESALSR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server